Contact Us

News

  • Hon’ble delegation member of CII

    Managing Director Mr. Alok Kumar – Hon’ble delegation member of CII delegation to Minsk Belarus 24th Sept 2018, announced upcoming investment and business with Belarus.

    2018-09-27 14:45:29

  • Onco plant at Goa

    Onco plant at Goa -internal and external infra works are in full swing target to operational by 4th quarter of 2018

    2018-09-27 14:47:06

  • Managing Director Mr. Alok Kumar

    Managing Director Mr. Alok Kumar - Invitee guest during opening of Belarus Consulate at Mumbai

    2018-09-27 14:48:13

  • Plant 1 OSD , 4 Dept

    Plant 1 OSD , 4 Dept, Atgaon, Thane ,India - Russian GMP, Belarus GMP and PIC/s Certified.

    2018-09-27 14:48:45

  • Domestic Market

    3 new products are schedule to launch for Anti fungal, Laxative and Respiratory

    2018-12-04 10:37:57

  • Message 1

    7-Mar-2019 10:00 AM: Opening Ceremony of Novalok LLC (Oral Solid Dose Plant) at Belarus, 31761, Grodno District, SKidel, st. Kizevich 50

    2019-03-07 13:43:05

Quote

  • Competition makes things come out right. Well, what does that mean in health care? More hospitals so they compete with each other. More doctors compete with each other. More pharmaceutical companies. We set up war. Wait a minute, let's talk about the patient. The patient doesn't need a war.
    Donald Berwick

Overview
 

Past: Concept of backward integration from exporting to Manufacturing was conceived by Mr. Alok Kumar (Founder and Managing Director) in early millennium era when entire world was busy with Y2K issue. Lok-Beta commenced its activity in Apr-2002 from Mumbai, India with a range of Pharmaceutical and Healthcare products across globe along with plan to establish its own ultra modern manufacturing plant. First fully integrated Manufacturing Unit along with R&D centre operationalized supported by Warehouse as per GDP in 2008. First accreditations WHO-GMP, India received in Sep-2009. First overseas head quarter established in the heart of Moscow city, Russia in 2006.

Present

Lok-Beta is currently investing heavily in the research and development of new Pharmaceuticals & Healthcare formulations. The next few years will see a stream of new Lok-Beta products being established in the market Infrastructure:

  • Total area of constructed (RCC) factory is 4500 Sq.M
  • Tablets, Capsules, Liquid Suspension, Syrup, Ointment and Cream
  • GLP, FDA Maharashtra, India certified Laboratory, ISO 9001:2015  
  • WHO-GMP, PIC/s, Russian GMP and other international accreditation
  • Market : More than 32 countries in Asia, Africa and Latin America. At domestic front company has presence in 4 states.
Way Forward
  • Skidel, Belarus plant – Oral dose Formulation & API . Manufacturing facility in 3rd quarter of 2018 (API in 3rd quarter of 2019)
  • GOA plant focusing on Oncology manufacturing – Sterile formulation with API non-sterile facility in 4th quarter of 2018
  • Annually 10 new products registration
  • EU approval (Pre qualification with EU GMP schedule in 2019)